Single-Cell AML Mapping Finds Chemoresistant States

Company Baylor College of Medicine Event Type Publication / Peer-Reviewed Study Modality Single-Cell Transcriptomic Risk Classifier Asset LR2-High Chemoresistant Signature (Research) Target FLT3 / CDK4/6 / Retinoid Signaling (Nominated Vulnerabilities) Disease Area Pediatric Acute Myeloid Leukemia Summary A peer-reviewed pediatric AML study integrates paired diagnosis–relapse…